How to Manage Finances During and After Cancer Treatment in the UK
· Gena Health Team
A cancer diagnosis is not just a medical event. It affects every part of life, including your finances. While the NHS covers most clinical costs, the broader financial burden can be significant, particularly during long treatment journeys or when seeking options outside the standard of care. Understanding where costs arise, what help is available, and how to plan ahead can make a big difference to your peace of mind and long-term stability.
This guide is designed to help cancer patients and carers in the UK navigate the financial implications of diagnosis and treatment, drawing on the latest data and resources available.
Cancer Treatments: What Is Covered by the NHS, and What Isn’t?
The NHS remains one of the world’s most comprehensive healthcare systems, and for most patients, primary treatment is fully covered. However, costs can arise around the edges - often hidden at first, but mounting over time.
Surgery
Often the first step in treating solid tumours, surgery is fully funded by the NHS. But costs still emerge:
Time off work during recovery
The need for post-operative care at home
Travel for pre- and post-operative appointments
Chemotherapy
NHS hospitals provide chemotherapy drugs and treatment without charge. However, globally, many chemotherapy agents cost up to £25,000 per month, creating budgetary pressure on healthcare systems. In the UK, the Cancer Drugs Fund ensures many of these high-cost drugs remain available to patients without direct payment.
Radiation Therapy
Radiotherapy is also free on the NHS but often requires multiple visits over several weeks, which can lead to:
Significant travel time and costs
Loss of earnings due to repeated time off work
Immunotherapy and Targeted Treatments
Newer cancer treatments such as immunotherapy and targeted therapies have transformed outcomes but are some of the most expensive options. Internationally, these treatments can cost tens of thousands per month. In the UK, the NHS has prioritised access to these where approved, and in some cases, introduced innovative 5-minute ‘super jabs’ to streamline care without increasing cost to the patient.
Another example of an immunotherapy is CAR-T therapy which modify a patient’s immune cells to attack cancer. This is priced in the hundreds of thousands internationally. In the UK, CAR-T therapy is available at select NHS centres for eligible patients with certain blood cancers such as acute lymphoblastic leukaemia and diffuse large B-cell lymphoma. Access is determined by strict clinical criteria, and treatment is delivered through a small number of specialist hospitals. While there are no direct treatment costs for eligible patients, indirect costs - including travel to major centres, time off work, and the need for specialist aftercare - may still arise.
The Hidden and Indirect Costs of Cancer
Even with excellent NHS coverage, patients and families often find themselves under financial strain due to:
Travel and Accommodation: For those living far from specialist centres, repeated trips can rack up fuel, train fares, and sometimes overnight stays.
Loss of Income: Cancer treatment can interrupt careers. Whether it’s short-term sick leave or long-term absence, earnings often fall. According to recent analysis, UK employers are expected to face up to £8.5 billion in costs due to cancer-related absence in 2025, reflecting the knock-on effect on household finances.
Supportive Care Costs: This includes home care, mobility aids, dietary supplements, and private physiotherapy or counselling, which are not always NHS-funded.
Mental Health and Wellbeing: Although some psychological support is available via the NHS, demand often exceeds supply. Private counselling or complementary therapies like massage or acupuncture can help but add to financial strain.
Financial Support Schemes in the UK
Fortunately, there are a range of financial assistance options for those undergoing cancer treatment.
NHS Support
The Healthcare Travel Costs Scheme can help with travel to hospital appointments for those receiving certain benefits. Prescriptions are free for cancer patients in across the UK.
Statutory Sick Pay (SSP) and Employment and Support Allowance (ESA)
SSP can be claimed for up to 28 weeks if you're employed but too ill to work. For those needing longer-term support or who are self-employed, ESA provides further financial assistance.
Personal Independence Payment (PIP)
This is a benefit for those with long-term health conditions or disabilities. Many cancer patients qualify due to treatment-related challenges with mobility, fatigue, or day-to-day activities.
Universal Credit
Those out of work or on low income may be eligible for Universal Credit. It includes housing support and can be adjusted to reflect health-related circumstances.
Charity and Third-Sector Help
Organisations like Macmillan Cancer Support, Maggie’s Centres and Shine Cancer Support offer:
Emergency grants for heating, travel, or special equipment
Financial counselling and benefits advice
Free support workers who can assist with paperwork and appeals
6 Tips for Financial Resilience During and After Treatment
Navigating the financial side of cancer is not just about reacting - it’s about planning ahead and using support wisely.
1. Tell Your Employer Early
Being upfront about your diagnosis allows you to explore flexible working, sick leave, or phased returns. Employers have a duty to make reasonable adjustments.
2. Keep Detailed Records
Save documentation for every appointment, expense, and benefits application. This can help with claims, appeals, and even tax returns.
3. Get Expert Help
Financial advisors, social workers, or charity benefits advisors can save you time and stress. Macmillan has dedicated support teams who specialise in navigating cancer-related finances.
4. Review Your Insurance and Mortgage Protections
Check whether you have critical illness cover or mortgage protection through work or private plans. You may be entitled to lump sum payments or deferred payment schemes.
5. Budget for the Long-Term
Survivorship comes with its own costs: follow-up scans, late side effect management, and medication. Make room in your plan for ongoing needs.
6. Ask About Alternative Access Routes
Clinical Trials, Expanded Access Programmes (EAPs), Early Patient Access Schemes (EPAs) and Compassionate Use schemes may be relevant for some patients, especially those with rare cancers or who have exhausted standard treatments. Alternative access routes can offer cutting-edge therapies at little or no personal cost.
Alternative Access Routes Explained
Clinical Trials
Trials funded by the NHS, universities, or pharmaceutical companies can provide access to new drugs or treatment combinations. Participants often receive treatment, diagnostics, and monitoring at no cost, and trials may also reimburse travel or provide stipends. The NHS and organisations like Cancer Research UK maintain searchable databases of available trials.
Early Patient Access Schemes (EPAs)
These allow patients to access promising new treatments before full NHS approval. They are often funded by the drug manufacturer and evaluated under a managed access agreement. The MHRA’s Early Access to Medicines Scheme (EAMS) provides a formal route for this in the UK.
Expanded Access Programmes (EAPs)
These are manufacturer-led programmes that make investigational drugs available to groups of patients who are not eligible for clinical trials and have limited or no standard treatment options. Like EPAs, they are typically offered at no cost to the patient and require clinician involvement. Travel and monitoring needs may still apply.
Compassionate Use or Named Patient Access
When no suitable clinical trial or approved treatment is available, clinicians may apply for individual access to experimental or unlicensed drugs directly from pharmaceutical companies. This is typically at no cost to the patient, although travel and monitoring requirements still apply. Patients should discuss this route with their oncologist, as access is based on clinical judgement and company discretion.
While these alternative routes can open up life-extending or life-saving treatments, they require careful evaluation of risks, benefits, and logistics. Patients should ask their care team or a trusted advisor whether any such options may be appropriate in their situation.
Brexit and the Cost of Cancer
While the NHS continues to shield patients from the worst financial impacts, systemic pressures remain. The UK’s post-Brexit position has complicated access to new cancer drugs, with some companies deprioritising UK launches due to regulatory and cost hurdles.
This could delay access to newer drugs or clinical trials. However, the NHS is adapting - by fast-tracking approvals, increasing domestic trials, and leveraging initiatives like the Cancer Drugs Fund to maintain patient access.
Key Takeaways
The NHS provides world-class cancer care without direct costs, but indirect financial burdens still affect many patients.
Support is available, but often underused. Charities, benefits advisors, and workplace schemes can help ease the load.
Planning ahead - including budgeting for long-term needs is essential, especially for those facing longer treatment or recovery.
Patients should not hesitate to ask for help, whether from healthcare teams, local councils, or charities like Macmillan.
Post-Brexit pressures may affect drug availability and trials, but the NHS is innovating to protect patient access wherever possible.
Useful Links and Resources
If you're navigating a cancer diagnosis or supporting a loved one, Gena is here to help you understand your options. From treatment matching to emotional and practical support, we aim to make cancer care more accessible, transparent and personal.
Need help understanding your treatment options? Get started with Gena today.